Understanding the New At-Home Cervical Cancer Test
In the United States, approximately 25% of women, equating to around 21 million individuals, are not current with their cervical cancer screenings. This statistic highlights a significant gap in preventive healthcare.
Fortunately, a new advancement has emerged as Teal Health has earned FDA approval for an innovative cervical cancer test that women can now administer in the comfort of their own homes. This breakthrough is expected to make a substantial impact.
Expert Insights on the Development
Kara Egan, CEO of Teal Health, along with Dr. Celine Gounder, have been instrumental in discussing the implications of this development. Their insights provide a deeper understanding of how this new home test could transform women's health strategies.




Leave a Reply